Rosemary F. Zhang
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Rheumatoid Arthritis Research and Therapies, Melanoma and MAPK Pathways, Synthesis and biological activity, Computational Drug Discovery Methods
Most-Cited Works
- → 5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase(2005)70 cited
- → Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases(2010)57 cited
- → Benzothiazole based inhibitors of p38α MAP kinase(2008)51 cited
- → Discovery of pyrrolo[1,2-b]pyridazine-3-carboxamides as Janus kinase (JAK) inhibitors(2014)30 cited
- → Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis(2019)14 cited
- → Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors(2017)13 cited
- → CCDC 1896615: Experimental Crystal Structure Determination(2019)